1-2 of 2
Hee-Je Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial

Clinical Trials & Observations
Gail J. Roboz, Guillermo Sanz, Elizabeth A. Griffiths, Karen Yee, Hagop Kantarjian, Christian Récher, Michael T. Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L. O'Connell, Yong Hao, Harold N. Keer, Mohammad Azab, Hartmut Döhner
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2020–2029.
https://doi.org/10.1182/bloodadvances.2023012062
Published: 2024
Includes: Supplemental data
Journal Articles

TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently

Han Sun Kim, Bo-Reum Kim, Thien T. P. Dao, Jin-Mo Kim, Yoon-Ju Kim, Hyunsong Son, Sihyang Jo, Doyeon Kim, Jiwoo Kim, Young Ju Suh, Hee-Je Kim, Byung-Sik Cho, Sunghyouk Park
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3155–3168.
https://doi.org/10.1182/bloodadvances.2022007956
Published: 2023
Includes: Supplemental data